CN101822726B - 一种具有保肝护肝作用的药品或者保健食品 - Google Patents
一种具有保肝护肝作用的药品或者保健食品 Download PDFInfo
- Publication number
- CN101822726B CN101822726B CN2010101433810A CN201010143381A CN101822726B CN 101822726 B CN101822726 B CN 101822726B CN 2010101433810 A CN2010101433810 A CN 2010101433810A CN 201010143381 A CN201010143381 A CN 201010143381A CN 101822726 B CN101822726 B CN 101822726B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- protection function
- add
- liver protection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 235000013305 food Nutrition 0.000 title abstract description 4
- 229940079593 drug Drugs 0.000 title description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 45
- 239000012567 medical material Substances 0.000 claims description 16
- 241000219780 Pueraria Species 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 9
- 235000013402 health food Nutrition 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims 1
- 238000002481 ethanol extraction Methods 0.000 claims 1
- 230000007774 longterm Effects 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 abstract description 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 description 5
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 4
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101001031591 Mus musculus Heart- and neural crest derivatives-expressed protein 2 Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101433810A CN101822726B (zh) | 2010-03-09 | 2010-03-09 | 一种具有保肝护肝作用的药品或者保健食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101433810A CN101822726B (zh) | 2010-03-09 | 2010-03-09 | 一种具有保肝护肝作用的药品或者保健食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101822726A CN101822726A (zh) | 2010-09-08 |
CN101822726B true CN101822726B (zh) | 2011-08-24 |
Family
ID=42687030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101433810A Active CN101822726B (zh) | 2010-03-09 | 2010-03-09 | 一种具有保肝护肝作用的药品或者保健食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101822726B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102631455B (zh) * | 2012-04-26 | 2014-03-05 | 吉林大学珠海学院 | 一种具有解酒保肝活性的中药复方制剂及其制备方法 |
CN103656277B (zh) * | 2013-11-27 | 2015-08-19 | 潍坊市现代风湿病研究院 | 治疗肝腹水的药物 |
CN103948028B (zh) * | 2014-04-20 | 2017-03-22 | 江苏康缘药业股份有限公司 | 一种具有缓解肝损伤作用的组合物及其制备方法 |
CN104547215A (zh) * | 2014-11-29 | 2015-04-29 | 张莘蔓 | 一种含积雪草的中药组合物 |
CN105795177A (zh) * | 2014-12-29 | 2016-07-27 | 伊启棒(天津)科技发展有限公司 | 一种用于保肝护肝的保健食品 |
CN104814429A (zh) * | 2015-04-10 | 2015-08-05 | 山东安然纳米实业发展有限公司 | 一种具有保肝、护肝、调节血脂功能的保健食品 |
CN107753627A (zh) * | 2016-08-22 | 2018-03-06 | 北京大伟嘉生物技术股份有限公司 | 一种用于治疗动物肝脏病变的中药组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1115663A (zh) * | 1995-05-08 | 1996-01-31 | 陈荣升 | 治疗高血压病的药物 |
CN101642531A (zh) * | 2009-06-15 | 2010-02-10 | 张继成 | 健脾肺降血糖胶囊 |
-
2010
- 2010-03-09 CN CN2010101433810A patent/CN101822726B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1115663A (zh) * | 1995-05-08 | 1996-01-31 | 陈荣升 | 治疗高血压病的药物 |
CN101642531A (zh) * | 2009-06-15 | 2010-02-10 | 张继成 | 健脾肺降血糖胶囊 |
Non-Patent Citations (2)
Title |
---|
李 彬.解酒肝康汤治疗酒精性脂肪肝临床疗效评价.《光明中医》.2007,第22卷(第9期), * |
李崇安.中药治疗乙型肝炎150 例的药物分析研究.《中国民族民间医药杂志》.2002,(第4期), * |
Also Published As
Publication number | Publication date |
---|---|
CN101822726A (zh) | 2010-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101822726B (zh) | 一种具有保肝护肝作用的药品或者保健食品 | |
CN106237075B (zh) | 一种具有抗疲劳和提升注意力作用的食品、保健品或者药物组合物及其制备方法和用途 | |
CN102727680B (zh) | 一种降血脂的中药及制备方法 | |
CN106135891A (zh) | 一种对酒精性肝损伤具有保护功能的保健食品 | |
CN103341052A (zh) | 一种预防和治疗高血压、高血脂、高血糖、低血压药物及其制作方法 | |
CN102068494B (zh) | 对化学性肝损伤有治疗作用的保健胶囊及其制备方法 | |
CN102526671A (zh) | 一种预防治疗咳嗽感冒的中药组合物及其配制方法 | |
CN101143202B (zh) | 一种对化学性肝损伤具有保护作用的复方口服制剂 | |
CN103372051B (zh) | 一种调节血脂的红曲葛根药物组合及其制备方法 | |
CN102038774B (zh) | 一种具有降脂保肝作用的药品或者保健食品 | |
CN101829274A (zh) | 一种治疗肝病的药物 | |
CN103372073A (zh) | 一种调节血脂的红曲山楂药物组合及其制备方法 | |
CN100375614C (zh) | 一种退黄保肝的舒肝宁滴丸及其制备方法 | |
CN104056178A (zh) | 一种具有促进消化功能的中药组合物及其应用 | |
CN106038702B (zh) | 抗疲劳的组合物及其制备方法和应用 | |
CN102000250B (zh) | 一种乌鸡保健药物及其制备方法和应用 | |
CN105617251B (zh) | 一种治疗抑郁症的中药组合物及其制备方法 | |
CN103372040B (zh) | 一种调节血脂的红曲川芎药物组合及其制备方法 | |
CN103083446A (zh) | 一种预防弓形虫病的中药组合物 | |
CN103372114B (zh) | 一种调节血脂的红曲泽泻药物组合及其制备方法 | |
CN1528427A (zh) | 一种治疗甲状腺机能亢进的中成药 | |
CN103566349A (zh) | 一种治疗高血糖高血脂的药物组合物 | |
CN100358496C (zh) | 一种治疗脑炎、肝昏迷的醒脑静滴丸及其制备方法 | |
CN102895334A (zh) | 一种甘草附子汤整合型新剂型制备技术及其生产方法 | |
CN103301380A (zh) | 一种疏肝理气的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: KUANG DAIWU Effective date: 20131009 Owner name: YANTAI FUSHENGTANG HEALTH CARE PRODUCTS CO., LTD. Free format text: FORMER OWNER: YANTAI DAYANG PHARMACEUTICAL GROUP Effective date: 20131009 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20131009 Address after: 265500 Yantai, Fushan District, Shandong Telecom Road, No. 530 Patentee after: Yantai Fushengtang Health-care Products Co.,Ltd. Address before: 265500 Yantai, Fushan District, Shandong Telecom Road, No. 530 Patentee before: Yantai Dayang Pharmaceutical Co., Ltd. Patentee before: Kuang Daiwu |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170329 Address after: 264006 Shenzhen street, Yantai Development Zone, Shandong, No. 79 Patentee after: Kuang Daiwu Address before: 265500 Yantai, Fushan District, Shandong Telecom Road, No. 530 Patentee before: Yantai Fushengtang Health-care Products Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180129 Address after: 264006 Shenzhen street, Yantai Development Zone, Shandong, No. 79 Patentee after: YANTAI BAOBEI BIOTECHNOLOGY CO., LTD. Address before: 264006 Shenzhen street, Yantai Development Zone, Shandong, No. 79 Patentee before: Kuang Daiwu |
|
TR01 | Transfer of patent right |